从资金流向上来看，当日动物保健板块主力资金净流入5981.69万元，游资资金净流入2201.21万元，散户 资金净流出8182.9万元。动物保健板块个股资金流向见下表： 证券之星消息，1月30日动物保健板块较上一交易日下跌0.23%，金河生物领跌。当日上证指数报收于 4117.95，下跌0.96%。深证成指报收于14205.89，下跌0.66%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300871 | 回盛生物 | 29.46 | 3.51% | 30.31万 | 9.01亿 | | 002868 | *ST绿康 | 35.79 | 1.97% | 1.12万 | 3943.24万 | | 920970 | 大禹生物 | 8.54 | 1.79% | 5.41万 | 4640.00万 | | 688098 | 申联生物 | 9.53 | 1.49% | 5.11万 | 4838.44万 | | 600195 | 中牧股份 | 8.17 | 0.74% | 2 ...

证券日报网讯1月29日，普莱柯（603566）在互动平台回答投资者提问时表示，公司按照相关规定在定 期报告中对股东总数进行披露。 ...

从资金流向上来看，当日动物保健板块主力资金净流入1802.32万元，游资资金净流出2735.26万元，散户 资金净流入932.94万元。动物保健板块个股资金流向见下表： 证券之星消息，1月28日动物保健板块较上一交易日下跌0.2%，永顺生物领跌。当日上证指数报收于 4151.24，上涨0.27%。深证成指报收于14342.9，上涨0.09%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 18.78 | 1.51% | 71.49万 | | 13.16亿 | | 002688 | 金河生物 | 6.80 | 1.49% | 37.94万 | | 2.55 Z | | 920970 | 大禹生物 | 8.35 | 1.46% | 4.01万 | | 3369.19万 | | 002868 | *ST绿康 | 35.41 | 0.03% | 2.68万 | | 9485.97万 | | 600195 | 中牧股份 | 8. ...

1月27日，普莱柯大宗交易成交18.08万股，成交额252.4万元，占当日总成交额的2.15%，成交价13.96 元，较市场收盘价13.96元持平。 | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | | | 卖出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 026-01-27 | 曾秦柯 | 603566 | 13.96 252.4 | 18.08 | 去筒迁落劈绞有限 | 去筒是蒙臂发幕露 | | 190 | ...

证券之星消息，1月27日动物保健板块较上一交易日下跌2.78%，回盛生物领跌。当日上证指数报收于 4139.9，上涨0.18%。深证成指报收于14329.91，上涨0.09%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 2988.76万 | 24.73% | -4066.41万 | -33.65% | 1077.65万 | 8.92% | | 600195 中牧股份 | | 2127.67万 | 5.68% | 4526.16万 | 12.07% | -6653.83万 | -17.75% | | 002688 金河生物 | | 1929.37万 | 5.73% | -1475.90万 | -4.39% | -453.46万 | -1.35% | | 300119 瑞普生物 | | 1604.24万 | 5.07% | 1360.73万 | 4.3 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 920729 | 永顺生物 | 11.79 | 27.18% | 29.26万 | | 3.28亿 | | 300871 | 回盛生物 | 32.62 | 20.01% | 38.37万 | | 11.83亿 | | 603718 | 海利生物 | 7.02 | 7.18% | 62.11万 | | 4.34亿 | | 688526 | 科前生物 | 17.79 | 6.78% | 13.60万 | | 2.36亿 | | 002688 | 金河生物 | 6.77 | 5.95% | 69.40万 | | 4.62亿 | | 600195 | 中牧股份 | 8.96 | 5.54% | 46.58万 | | 4.10亿 | | 300119 | 瑞普生物 | 21.44 | 5.20% | 20.01万 | | 4.22亿 | | 600201 | 生物股份 | 18.13 | 4.50% | 56.49万 | | 10.15 乙 ...

Investment Rating - The report maintains an investment rating of "Outperform" for the agriculture, forestry, animal husbandry, and fishery industry [1]. Core Insights - The report highlights a weak fluctuation in pig prices, with the average price in December 2025 at 11.58 yuan/kg, down 0.09% month-on-month and down 26.76% year-on-year. However, a supply gap for heavy pigs is expected to lead to a price rebound [9][19]. - The white feather chicken prices showed an upward trend in December, with an average price of 3.67 yuan/jin, up 5.16% month-on-month, supported by tight supply and demand [9][25]. - Pet food exports maintained a year-on-year growth, with December 2025 exports at 37,700 tons, up 15.49% year-on-year, although the export value in USD decreased by 1.68% [9][32]. Summary by Sections Market Review - In December 2025, the agriculture, forestry, animal husbandry, and fishery index rose by 0.24%, ranking 22nd among 30 sectors, while the Shanghai and Shenzhen 300 index increased by 2.28%, indicating a 2.04 percentage point underperformance [9][12]. Livestock Industry Data Tracking - **Pig Farming**: The average price of pigs in December was 11.58 yuan/kg, with a month-on-month decrease of 0.09% and a year-on-year decrease of 26.76%. The supply-demand dynamics are expected to stabilize, with a potential increase in prices due to supply gaps [19][24]. - **White Feather Chicken**: The average price for white feather chicken in December was 3.67 yuan/jin, reflecting a month-on-month increase of 5.16% due to tight supply and demand support [25][29]. Pet Food - Pet food exports in December reached 37,700 tons, a year-on-year increase of 15.49%, while the total export value for the year was 1.412 billion USD, down 4.62% year-on-year [32][34]. Investment Recommendations - The report suggests focusing on companies such as Muyuan Foods, Pulaike, and Guobao Pet, all rated as "Buy" based on their earnings forecasts and relative valuation [1][9].

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 17.35 | -1.42% | 31.57万 | 5.51亿 | | 603566 | 普莱柯 | 13.78 | -0.72% | 5.94万 | 8171.47万 | | 600195 | 中牧股份 | 8.49 | -0.59% | 14.59万 | 1.23亿 | | 002868 | *ST绿康 | 37.28 | -0.43% | 8137.0 | 3038.12万 | | 300119 | 瑞普生物 | 20.38 | -0.39% | 4.53万 | 9258.76万 | | 002141 | 贤丰控股 | 4.19 | 0.00% | 154.61万 | 6.70亿 | | 688098 | 申联生物 | 9.97 | 0.10% | 5.22万 | 5205.80万 | | 002688 | 金河生物 | 6.39 | 0.16% | 13.54万 | 8616.98万 | | 688526 | ...

Core Viewpoint - The animal health sector experienced a decline of 0.65% on January 21, with Huisheng Biological leading the drop. The Shanghai Composite Index rose by 0.08%, while the Shenzhen Component Index increased by 0.7 [1] Group 1: Stock Performance - The closing prices and performance of key stocks in the animal health sector showed varied results, with Shunlian Biological up by 4.20% and Huisheng Biological down by 6.19% [1][2] - The trading volume for Huisheng Biological was 419,900 shares, with a transaction value of 1.192 billion yuan, indicating significant market activity despite the decline [2] Group 2: Capital Flow - The animal health sector saw a net inflow of 9.6935 million yuan from institutional investors, while retail investors experienced a net outflow of 73.8174 million yuan, suggesting a shift in investor sentiment [2][3] - Among individual stocks, Xianfeng Holdings had a net inflow of 15.1182 million yuan from institutional investors, while Huisheng Biological saw a net outflow of 42.2249 million yuan from retail investors [3]

Group 1: Delisting Risks - *ST Xin Yan: The Shenzhen Stock Exchange has approved the company's application to revoke the delisting risk warning due to restructuring [1] - *ST Zhong Zhuang (Rights Protection): The delisting risk warning has been revoked, but other risk warnings will continue, and the stock will be suspended for one day starting tomorrow [2] - ST Sai Wei: Expected to incur a loss of 720 million to 1.02 billion yuan in 2025, with a possibility of being subject to delisting risk warnings [3] Group 2: Earnings Forecasts - Hikvision: Expected net profit attributable to shareholders to grow by 18.46% year-on-year in 2025 [28] - Langzi Co.: Expected net profit to increase by 245.25% to 302.8% year-on-year in 2025 [4][30] - Zhaoyan New Drug: Expected net profit to increase by 214% to 371% year-on-year in 2025 [5][30] - Huachen Equipment: Expected net profit to increase by 193.64% to 242.04% year-on-year in 2025 [6][30] - Qianyuan Power: Expected net profit to increase by 160% to 190% year-on-year in 2025 [7][30] - Jin Fang Energy: Expected net profit to increase by 123.97% to 193.7% year-on-year in 2025 [8][31] - Zhongfu Industrial: Expected net profit to increase by 120.27% to 141.59% year-on-year in 2025 [9][32] - Batian Co.: Expected net profit to increase by 117.53% to 139.53% year-on-year in 2025 [10][32] - Zhongrong Electric: Expected net profit to increase by 104.89% to 131.10% year-on-year in 2025 [11][32] - Kaisheng New Materials: Expected net profit to increase by 96.47% to 150.06% year-on-year in 2025 [12][32] - Putailai: Expected net profit to increase by 93.18% to 101.58% year-on-year in 2025 [13][32] - Dongfang Iron Tower: Expected net profit to increase by 91.4% to 125.07% year-on-year in 2025 [14][32] - Pulaike: Expected net profit to increase by 89.64% to 110.11% year-on-year in 2025 [15][32] - Huabang Health: Expected profit of 660 million to 730 million yuan in 2025, turning from loss to profit [16][32] - Hongyuan Green Energy: Expected net profit of 180 million to 250 million yuan in 2025, turning from loss to profit [17][32] - Kangda New Materials: Expected profit of 125 million to 135 million yuan in 2025, turning from loss to profit [18][32] - Langxin Technology: Expected profit of 100 million to 150 million yuan in 2025, turning from loss to profit [19][32] - Hualv Biological: Expected profit of 100 million to 130 million yuan in 2025, turning from loss to profit [20][32] Group 3: Mergers and Acquisitions - Kangxin New Materials: Plans to acquire 51% of Yubang Semiconductor for 392 million yuan [21][32] - Aibo Medical: Plans to gain control of Demei Medical [22][32] Group 4: Share Buybacks and Reductions - Hengtong Co.: Plans to repurchase company shares worth 80 million to 100 million yuan [24][32] - Haier Smart Home: Plans to repurchase D shares up to 200,000 euros [29][32] - Blue Universe Co.: Shareholders plan to reduce their holdings by no more than 3.02% [29][32] - Hesheng Silicon Industry: Controlling shareholder plans to reduce holdings by no more than 3% [29][32] - Aolian Electronics (Rights Protection): Shareholder Liu Junsheng plans to reduce holdings by no more than 3% [29][32] - Bluefeng Biochemical: Hainan Wenqin plans to reduce holdings by no more than 3% [29][32] - Zhixin Precision: Shareholders plan to reduce holdings by no more than 3% [29][32] - Peking University Medical: Peking University Health plans to reduce holdings by no more than 3% [29][32] Group 5: Other Updates - Liou Co.: Self-inspection work has been completed, and the stock will resume trading on January 21 [29][32] - Yongxing Materials: The lithium mica green intelligent and efficient lithium extraction project has reached production capacity [29][32] - Debang Co.: Plans to voluntarily withdraw A shares from trading on the Shanghai Stock Exchange [29][32]